drugset / Trial / NCT02710422

Miami Membrane for Potency (MMEP) Trial

NCT02710422 ↗

Phase 2 Terminated 24 enrolled University of Miami Vivex Biomedical · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The use of dehydrated human amnionic membrane allograft improves erectile function recovery (as measured by (Sexual History Inventory for Men (SHIM) score) at 12 months after robotic assisted radical prostatectomy (RARP) compared to a control group with no allograft.

Timeline

Start
2016-05-17
Primary completion
2019-01-22
Completion
2019-01-22

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of Accrual and Inadequate Funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Amniotic Membrane Allograft Unknown — —

Indications